Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CODI: IPV vs Fractional IPV Immunogenicity
NCT03286803Phase 4Unknown
- Sponsor
- Aga Khan University
- Start
- Aug 2017
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of trivalent inactivated polio vaccine in poliomyelitis, sponsored by Aga Khan University. Status: unknown.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03286803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03286803.